LIVZON PHARMA - stock earnings
1513.HK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | 581.9 million CNY | 3.4 billion CNY |
| 2022Q3 | 489.3 million HKD | 3.2 billion HKD |
| 2022Q2 | 464.3 million HKD | 2.8 billion HKD |
| 2022Q1 | 553.3 million HKD | 3.5 billion HKD |
| 2021Q4 | 323.0 million HKD | 2.7 billion HKD |
| 2021Q3 | 390.3 million CNY | 3.1 billion CNY |
| 2021Q2 | 542.8 million CNY | 2.9 billion CNY |
1513.HK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 1.8 billion CNY | 12.1 billion CNY |
| 2021 | 1.8 billion HKD | 12.1 billion HKD |
| 2020 | 1.3 billion HKD | 9.4 billion HKD |
| 2018 | 1.1 billion HKD | 8.9 billion HKD |
1513.HK
Price: HK$27.70
Dividend Yield: 0.05%
Forward Dividend Yield: 6.34%
Payout Ratio: 76.48%
Dividend Per Share: 1.74 HKD
Earnings Per Share: 2.28 HKD
P/E Ratio: 10.64
Exchange: HKG
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 393800
Market Capitalization: 32.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 10
DGR3: 10.17%
DGR5: 1.63%